Medigen Biotechnology Corp. (3176.TWO)
TWD 31.7
(-0.94%)
TWD 31.7
(-0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.15 Billion | 1.05 Billion | 3.92 Billion | 614.17 Million | 552.34 Million | 407.3 Million |
| Cost of Revenue | 540.39 Million | 982.87 Million | 1.38 Billion | 385.94 Million | 331.2 Million | 327.61 Million |
| Gross Profit | 617.32 Million | 73.06 Million | 2.53 Billion | 228.23 Million | 221.14 Million | 79.69 Million |
| Operating Expenses | 1.85 Billion | 1.74 Billion | 1.74 Billion | 1.14 Billion | 983.47 Million | 842.11 Million |
| Selling, General and Administrative Expenses | 514.08 Million | 421.34 Million | 369.21 Million | 337.03 Million | 319.23 Million | 290.24 Million |
| Research and Development Expenses | 1.33 Billion | 1.31 Billion | 1.37 Billion | 803.37 Million | 664.24 Million | 551.87 Million |
| Other Expenses | - | 87.14 Million | 461.93 Million | 114.98 Million | - | - |
| Cost and Expenses | 2.39 Billion | 2.72 Billion | 3.13 Billion | 1.52 Billion | 1.31 Billion | 1.16 Billion |
| Operating Income | -1.23 Billion | -1.66 Billion | 789.2 Million | -912.17 Million | -762.32 Million | -762.41 Million |
| Interest Expense | 55.85 Million | 39.45 Million | 19.06 Million | 31.88 Million | 31.59 Million | 23.11 Million |
| Income Tax Expense | 191.2 Million | 58.87 Million | 65.73 Million | -32.63 Million | 8.72 Million | 15.99 Million |
| Earnings before Tax | -1.27 Billion | -1.61 Billion | 1.23 Billion | -825.43 Million | -759.53 Million | -784.46 Million |
| Net Income | -561.29 Million | -675.87 Million | -52.61 Million | -337.92 Million | -255.71 Million | -442.66 Million |
| Earnings Per Share Basic | -4.03 | -4.86 | -0.38 | -2.43 | -1.84 | -3.19 |
| Earnings Per Share Diluted | -4.03 | -4.86 | -0.38 | -2.43 | -1.84 | -3.19 |
| Weighted Average Shares Outstanding | 139.34 Million | 139.12 Million | 138.97 Million | 138.98 Million | 138.68 Million | 138.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 139.34 Million | 139.12 Million | 138.97 Million | 138.98 Million | 138.68 Million | 138.68 Million |
| Gross Margin | 0.53 | 0.07 | 0.65 | 0.37 | 0.40 | 0.20 |
| EBIT Margin | -0.90 | -1.40 | 0.25 | -1.13 | -0.99 | -1.35 |
| Profit Margin | -0.48 | -0.64 | -0.01 | -0.55 | -0.46 | -1.09 |
| EBITDA | -1.04 Billion | -1.47 Billion | 1.45 Billion | -574.71 Million | -567.34 Million | -549.48 Million |
| Earnings Before Tax Margin | -1.07 | -1.58 | 0.20 | -1.49 | -1.38 | -1.87 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 354.1 Million | 251.31 Million | 1.15 Billion | 371.02 Million | 416.88 Million | 205.56 Million |
| Cost of Revenue | 148.39 Million | 115.31 Million | 640.62 Million | 202.58 Million | 200.14 Million | 100.64 Million |
| Gross Profit | 205.71 Million | 136 Million | 517.1 Million | 168.43 Million | 216.74 Million | 104.91 Million |
| Operating Expenses | 233.55 Million | 275.34 Million | 1.75 Billion | 722.72 Million | 302.38 Million | 456.23 Million |
| Selling, General and Administrative Expenses | 138.24 Million | 119.81 Million | - | 129.79 Million | 138.15 Million | 98.1 Million |
| Research and Development Expenses | 95.31 Million | 155.53 Million | - | 592.93 Million | 164.23 Million | 358.12 Million |
| Other Expenses | 77.75 Million | 37.33 Million | 13.28 Million | -46.34 Million | 30.22 Million | 26.36 Million |
| Cost and Expenses | 381.95 Million | 390.65 Million | 2.39 Billion | 925.31 Million | 502.52 Million | 556.87 Million |
| Operating Income | -27.84 Million | -139.34 Million | -1.23 Billion | -554.29 Million | -85.64 Million | -351.31 Million |
| Interest Expense | 10.11 Million | 14.37 Million | 55.85 Million | 14.04 Million | 14.37 Million | 13.92 Million |
| Income Tax Expense | 10.58 Million | 9.91 Million | 191.2 Million | 161.06 Million | 11.4 Million | 12.02 Million |
| Earnings before Tax | 59.27 Million | -107.01 Million | -1.18 Billion | -595.75 Million | -51.58 Million | -307.44 Million |
| Net Income | 11.94 Million | -75.74 Million | -561.29 Million | -322.16 Million | -47.1 Million | -97.33 Million |
| Earnings Per Share Basic | 0.09 | -0.54 | - | -2.31 | -0.34 | -0.70 |
| Earnings Per Share Diluted | 0.09 | -0.54 | - | -2.31 | -0.34 | -0.70 |
| Weighted Average Shares Outstanding | 139.23 Million | 139.15 Million | 139.34 Million | 139.34 Million | 139.14 Million | 139.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 139.23 Million | 139.15 Million | 139.34 Million | 139.34 Million | 139.14 Million | 139.14 Million |
| Gross Margin | 0.58 | 0.54 | 0.45 | 0.45 | 0.52 | 0.51 |
| EBIT Margin | 0.04 | -0.38 | - | -1.38 | -0.10 | -1.49 |
| Profit Margin | 0.03 | -0.30 | -0.48 | -0.87 | -0.11 | -0.47 |
| EBITDA | 15.38 Million | -95.21 Million | - | -510.25 Million | -41.29 Million | -306.08 Million |
| Earnings Before Tax Margin | -0.08 | -0.55 | -1.07 | -1.49 | -0.21 | -1.71 |
NHC
BCIC
4537
ALRPD
0ROQ
CINDRELL